Advanced Biomedical Technologies

ABMT · OTC

$0.0005+$0.0095 (−105.56%)TodayMarket closed · Sep 24, 11:08 AM ET

No price history for this range.

About ABMT

Advanced BioMedical Technologies, Inc. engages in the business of designing, developing, manufacturing, and marketing biomaterial internal fixation devices. The company is headquartered in New York City, New York. The company went IPO on 2007-09-10. The Company’s primary products include Polymer Osteosynthesis Devices made of a proprietary material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly (methyl methacrylate-co-N-vinylpyrrolidone) (P(MMA-co-NVP)). These advanced materials are used in surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials and its PA Mini-Screws are under animal test.

Employees: 0
Headquarters: New York City, New York
Listed: Sep 10, 2007
Sector: Health Care
Industry: Health Care Equipment & Supplies
Website: abtlafleur.com

Leadership

Advanced Biomedical Technologies executives
Name	Title	Since	Age
Chiming Yu	—	2008	47
Hui Wang	—	2009	51
Kai Gui	—	—	51
Prof. Puyi Sheng	—	—	53

Similar companies

Companies in the same industry as Advanced Biomedical Technologies

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.